Survival analysis of transplant-associated thrombotic microangiopathy under different diagnostic criteria and the efficacy of plasma exchange

20 June 2023 : Original article

Yifan Xu

^12ABCDEF, Yan Wei^12BF, Lijun Wang^2BC, Ning Lu^2BD, Yongli Wu^2BD, Liping Dou^2AF, Daihong Liu

^2AF, Meng Li^2ADEF*, Chunji Gao^2ADEFG

DOI: 10.12659/AOT.939890

Ann Transplant 2023; 28:e939890

Background Material and Methods Results Discussion Conclusions References

Related articles Order reprints Share article Share by email

View HTML version

Table 4 Multivariable analyses affecting the overall survival of TA-TMA patients.

Variable	P value	HR	95% CI
III–IV aGVHD prior to TA-TMA	0.002	17.03	2.76–105.29
Renal or neurological dysfunction	0.021	7.40	1.30–40.80
Onset of TA-TMA diagnosis, median day post-HSCT	0.002	1.02	1.00–1.03
aGVHD – acute graft-versus-host disease; PE – plasma exchange.

Back to the Article